Rimegepant Sulfate
1 NDC across 1 manufacturer|0 Generic,1 Brand
Rimegepant Sulfate is used to treat migraine disorders, migraine with aura and migraine without aura, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Feb 27, 2020. In 2024, Medicare Part D spent $625 million on Rimegepant Sulfate across 427,000 claims for 105,000 beneficiaries.
Rimegepant Sulfate is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $128.67 to $128.67 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$128.67 – $128.67
per EA
7d Activity
avg +0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Pfizer Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Calcitonin Gene-related Peptide Receptor Antagonist class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing RIMEGEPANT SULFATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
NURTEC ODT 75 MG TABLET | $128.6698 per EA | +0.01% |
Frequently Asked Questions
What is Rimegepant Sulfate used to treat?
Rimegepant Sulfate is used to treat migraine disorders, migraine with aura and migraine without aura, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Rimegepant Sulfate?
In 2024, Medicare Part D spent $625 million on Rimegepant Sulfate across 427,000 claims for 105,000 beneficiaries.
How many Rimegepant Sulfate products are on the market?
The Rimegepant Sulfate drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Rimegepant Sulfate?
NADAC reference prices for Rimegepant Sulfate range from $128.6698 to $128.6698 per EA.
Which manufacturers make Rimegepant Sulfate?
1 manufacturer lists Rimegepant Sulfate in NADAC. Ranked by number of NDCs, the largest are Pfizer Inc. (1).
How has the price of Rimegepant Sulfate changed recently?
Over the past 7 days, 1 Rimegepant Sulfate NDC rose and 0 fell, with a market-wide average change of +0.0%.